Evaluation of contrast enhancement patterns in pancreatic tumors by coded harmonic sonographic imaging with a microbubble contrast agent

Journal of Ultrasound in Medicine

Volumn 22, Issue 8, 2003, Pages 789-795

  Nagase, Michitaka ^a   Furuse, Junji ^b   Ishii, Hiroshi ^b   Yoshino, Masahiro ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b NONE

Author keywords

Autoimmune related pancreatitis; Coded harmonic imaging; Contrast enhanced sonography; Endocrine carcinoma; Pancreatic cancer; SH U 508A

Indexed keywords

GASTROENTEROLOGY; IMMUNOLOGY; MEDICAL IMAGING; TUMORS;

PANCREATIC TUMORS;

ULTRASONIC APPLICATIONS;

CONTRAST MEDIUM; SHU 508;

ADOLESCENT; ADULT; ARTICLE; CANCER CLASSIFICATION; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; ECHOGRAPHY; FEMALE; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; PANCREAS CARCINOMA; PANCREAS DUCT; PANCREAS RESECTION; PANCREAS TUMOR; TUMOR VASCULARIZATION;

EID: 0042366307     PISSN: 02784297     EISSN: None     Source Type: Journal    
DOI: 10.7863/jum.2003.22.8.789     Document Type: Article

References (17)

1. Hosoki T. Dynamic CT on pancreatic tumors. AJR Am J Roentgenol 1983; 140:959-965.
2. Ghosh BC, Mojab K, Esfahani F, Moss GS, Das Gupta TK. Role of angiography in the diagnosis of pancreatic neoplasms. Am J Surg 1979; 138:675-677.
3. Ernst H, Hahn EG, Balzer T, Schlief R, Heyder N. Color Doppler ultrasound of liver lesions: signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound 1996; 24:31-35.
4. Kim AY, Choi BI, Kim TK, et al. Hepatocellular carcinoma, power Doppler US with a contrast agent: preliminary results. Radiology 1998; 209:135-140.
5. Hosten N, Puls R, Lemke AJ, et al. Contrast-enhanced power Doppler ultrasound: improved detection of characteristic flow patterns in focal liver lesions. J Clin Ultrasound 1999; 27:107-115.
6. Ding H, Kudo M, Onda H, et al. Evaluation of post-treatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology 2001; 221:721-730.
7. Choi BI, Kim AY, Lee JY, et al. Hepatocellular carcinoma: contrast enhancement with Levovist. J Ultrasound Med 2002; 21:77-84.
8. Furuse J, Nagase M, Ishii H, Yoshino M. Contrast enhancement patterns of hepatic tumours during the vascular phase using coded harmonic imaging and Levovist to differentiate hepatocellular carcinoma from other focal lesions. Br J Radiol 2003; 76:385-392.
9. Freeny PC, Marks WM, Ryan JA, Traverso LW. Pancreatic adenocarcinoma: diagnosis and staging with dynamic CT. Radiology 1988; 166:125-133.
10. Friedman AC. Pancreatic neoplasms and cysts. In: Friedman AC (ed). Radiology of the Liver, Biliary Tract, and Pancreas. St Louis, MO: CV Mosby Co; 1994:811.
11. Furukawa H, Iwata R, Moriyama N, Kosuge T. Selective intraarterial contrast-enhanced CT of pancreaticoduodenal tumors: early clinical experience in evaluating blood supply and detectability. AJR Am J Roentgenol 2000; 175:91-97.
12. Yassa NA, Yang J, Stein S, Johnson M, Ralls P. Gray-scale and color flow ultrasound of pancreatic ductal adenocarcinoma. J Clin Ultrasound 1997; 25:473-480.
13. Ding H, Kudo M, Onda H, Nomura H, Haji S. Sonographic diagnosis of pancreatic islet cell tumor: value of intermittent harmonic imaging. J Clin Ultrasound 2001; 29:411-416.
14. Sugiyama M, Atomi Y. Intraductal papillary mucinous tumors of the pancreas: imaging studies and treatment strategies. Ann Surg 1998; 228:685-691.
15. Okazaki K, Uchida K, Chiba T. Recent concept of autoimmune-related pancreatitis. J Gastroenterol 2001; 36:293-302.
16. Servais A, Pestieau SR, Detry O, et al. Autoimmune pancreatitis mimicking cancer of the head of pancreas: report of 2 cases. Acta Gastroenterol Belg 2001; 64:227-230.
17. Irie H, Honda H, Baba S, et al. Autoimmune pancreatitis: CT and MR characteristics. AJR Am J Roentgenol 1998; 170:1323-1327.